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Cells transduced ex vivo with transgenes encoded on
retroviruses have constant and prolonged expression
in vitro; however, in vivo expression is quickly lost.
Much attention has been directed at methods to cir-
cumvent this problem. We have shown that loss of
transgene expression does not occur when transduced
immortalized 3T3 cells are transplanted to the in vivo
setting of athymic mice. Ease of acquisition and poten-
tial for clinical application led us to assess the potential
of using immortalized human keratinocytes for expres-
sion of transgenes in vivo. Human keratinocytes were
immortalized with a HPV16-E6/E7 retrovirus, trans-
duced with a lacZ retrovirus, cloned by limiting dilu-
tion, seeded onto a physiologic dermal substrate,
A major hurdle for the clinical application of genetherapy is the fact that stable expression of thetransgene is quickly lost in vivo. Previous studies inour laboratory, using normal human fibroblasts, wereconducted to determine if loss of transgene expression
in vivo resulted from cell loss. Cells were transduced with a retroviral
vector encoding lacZ and cloned by limiting dilution. This protocol
generated a uniform population of cells with the same genotype
and phenotype, including identical insertion sites of the transgenes.
The cloned, transduced cells were expanded in vitro in a collagen
coated nylon matrix, transplanted to athymic mice, and followed
for 16 wk in vivo. These studies demonstrated that loss of transgene
expression in vivo was an organized event, most compatible with
apoptotic events (Krueger et al, 1997). Loss of transgene expression
was linked to the age of the cells: senescent fibroblasts were lost
more quickly in vivo than their nonsenescent counterparts (Krueger
et al, 1997). Importantly, immortalized fibroblasts (3T3 cells)
transduced with retroviral vectors did not lose expression in vivo
(Krueger et al, 1994; Petersen et al, 1995).
Loss of transgene expression by epidermal keratinocytes could
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and transplanted to athymic mice. Six weeks after
transplantation, the immortalized transgene
expressing keratinocytes had formed an epidermis that
was indistinguishable from one formed by nonimmor-
talized keratinocytes; furthermore, there was no loss
of expression of the lacZ gene. These observations
show that methods to extend cell survival are an
alternative approach to achieving stable and prolonged
expression of transgenes in vivo and that HPV16-E6/
E7 immortalized keratinocytes generate an epidermis
with normal morphology. Key words: genetically modified
keratinocytes/gene therapy/E6/E7 transformed cells. J Invest
Dermatol 112:233–239, 1999
not be studied in a similar fashion, because keratinocytes have a
limited life span in culture (µ20 cell doublings) in the defined
media we use and do not survive the rigors of cloning by limiting
dilution (repeated unpublished observations from our laboratory,
1998). Thus, methods to extend the life span of cultured ker-
atinocytes were examined. We chose to transduce keratinocytes
with a retroviral vector encoding the E6/E7 genes of human
papilloma virus, type 16 (HPV16) (Halbert et al, 1991, 1992). The
HPV16-E6/E7 genes inactivate tumor suppressor genes p53 and
Rb, thereby bypassing signals that normally lead to cell cycle arrest
in G1 (Demers et al, 1996). Transduction of keratinocytes with an
HPV16-E6/E7 retroviral vector will immortalize normal human
keratinocytes (IMKc) (Demers et al, 1996). It has been reported
that these IMKc form an epidermal structure with an altered
morphology when grown on a collagen raft in vitro (Halbert et al,
1992); however, the morphology of an epidermis generated from
and the expression of transgenes by HPV16-E6/E7 IMKc in vivo
has not been studied.
The aims of these studies were to assess the expression of stably
integrated transgenes in IMKc in vivo and to assess the morphology
of the epidermis formed by IMKc in vivo. This was accomplished
by introducing a second transgene (lacZ encoded on a retroviral
vector) into IMKc, subjecting these cells to cloning by limiting
dilution, expanding the lacZ expressing IMKc clones, seeding them
on a physiologic dermal substrate (de-epidermized human dermis,
DEHD), and transplanting this tissue construct to athymic mice.
These constructs were harvested and assessed for transgene expres-
sion and morphology at 4 and 6 wk after transplantation. Analysis
shows these IMKc form an epidermis that is indistinguishable from
an epidermis formed from nonimmortalized keratinocytes. In
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addition, there was no evidence of loss of expression of the marker
transgene (lacZ) in vivo, during this 6 wk proof of principle
experiment. This is in sharp contrast to the dramatic decrease in
transgene expression seen in similarly transduced normal ker-
atinocytes in vivo.
MATERIALS AND METHODS
Human keratinocytes (Kc) – source Keratinocytes were isolated from
neonatal foreskins using previously described methods (O’Keefe et al, 1982;
Boyce and Ham 1985). After harvest the cell suspension was subjected to
centrifugation, and re-suspended in keratinocyte growth medium (KGM)
(Clonetics, La Jolla, CA), plated at high density in 25 cm2 flasks, and
incubated at 37°C for 4–5 d, at which time colonies had started to form.
Medium was changed every other day, and cells were passaged when they
were 90%–95% confluent. Cells were harvested into sterile bovine calf
serum with 10% dimethylsulfoxide, placed in vials (1 3 106 per vial) and
cryopreserved in liquid nitrogen.
Kc – immortalization Foreskin keratinocytes (third passage) were
transduced with a retroviral vector encoding the E6 and E7 genes of type
16 human papilloma virus as well as neo (LXSN16E6/E7, kindly supplied
by D.A. Galloway of the Fred Hutchinson Cancer Research Center,
Seattle, WA) using a published protocol (Halbert et al, 1991). Transduced
cells were selected with G418, expanded in KGM, harvested into sterile
bovine calf serum with 10% dimethylsulfoxide, placed in vials (1 3 106
per vial), and cryopreserved in liquid nitrogen. Vials were recovered, cells
thawed, placed in KGM, expanded, and cloned using limiting dilution.
These clones have been passaged more than 50 times (µ150 cell doublings)
without reduction in growth rate. Under these growth conditions non-
HPV E6/E7 transduced keratinocytes undergo passage senescence after
about six passages (µ20 cell doublings). These HPV-E6/E7 keratinocytes
may not have yet reached the status of ‘‘immortal’’; however, their very
extended life span causes us to currently refer to them as immortalized
keratinocytes (IMKc).
Kc – transduction with lacZ The amphotropic packaging cell line (Ψ-
CRIP) producing α-SCG-lacZ virus (Dhawan et al, 1991) was grown to
near confluence in Dulbecco’s modified Eagle’s medium with 10% bovine
calf serum, washed with phosphate-buffered saline (PBS), and replaced
with KGM. Virus containing KGM was harvested 18 h later, filtered
through a 0.45 µm filter, and frozen in 5 ml aliquots at –70°C.
The IMKc were grown to µ50% confluence before transduction with
the supernatants containing lacZ virus. Flasks containing IMKc were
washed with PBS, and 2 ml of KGM containing lacZ virus was added to
each flask along with Polybrene, 4 µg per ml. Flasks were incubated at
37°C, swirling every 30 min; after 2 h the medium was replaced with
fresh KGM, cells were returned to the 37°C incubator, fed every other
day with new medium, harvested, and expanded when 90%–95% confluent.
A small portion of the cells was fixed with 0.5% glutaraldehyde in PBS
for 10 min at room temperature and stained for lacZ expression with
X-gal (Dannengerg and Suga, 1981). Approximately 40% of the cells
expressed lacZ.
Kc – cloning of IMKc transduced with lacZ The lacZ transduced
IMKc were cloned by limiting dilution (1 cell per well in 24 well plates).
Each clone was grown to near confluence and harvested; 90% of the cells
were transferred to a 35 mm tissue culture dish, and 10% were placed in
a well of a 96 well plate. These wells were analyzed for lacZ expression
using X-gal (Dannengerg and Suga, 1981) and lacZ positive clones
(IMKc.T.lacZ.c) were selected. The cells expressing the transgene in the
corresponding 35 mm tissue culture dish were expanded, harvested into
sterile bovine calf serum with 10% dimethylsulfoxide, placed in vials
(1 3 106 per vial), and cryopreserved. This second transduction and
expansion took the IMKc through additional passages and cell doublings.
Physiologic dermal substrate – source and seeding with IMKc Skin
from elective abdominoplasty surgery was dermatomed with a Paget
keratome to a thickness of 0.5 mm, cut into 1.5 3 1.5 cm2 squares, and
subjected to three rapid freeze-thaw cycles in liquid nitrogen. This skin
was placed in PBS with gentamycin (100 µg per ml), ciprofloxacin (10 µg
per ml), penicillin (50 IU per ml), streptomycin (50 µg per ml), and
amphotericin B (1 µg per ml), and incubated at 37°C for 3–4 d, at which
time the epidermis was peeled away from the dermis. Histologic analysis
revealed no viable cells and no remaining epidermis. The DEHD was
stored, papillary dermis side up, in autoclaved foil at –70°C.
To seed the DEHD with IMKc, pieces of DEHD were thawed, placed
papillary side up in 60 3 20 mm Petri dishes (1 DEHD per dish), and
1 3 106 normal Kc, IMKc, or IMKc.T.lacZ.c in 50–100 µl of KGM were
pipetted onto the surface of the DEHD. Before seeding, keratinocytes
were expanded to numbers sufficient for seeding; normal Kc were used
after the fifth passage (µ15 cell doublings), IMKc were used after the
seventeenth passage (µ51 cell doublings), and the IMKc.T.lacZ.c were
used after the eighteenth passage (µ54 cell doublings). These skin constructs
were incubated at 37°C for 3 h, 5 ml KGM was added (enough to cover
the construct), and placed in the 37°C incubator for 24 h. The KGM was
replaced with 10 ml of a medium which permits differentiation (KGM
60:40 Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum)
and proliferation, the constructs were returned to the 37°C incubator for
7–9 d, and the media was replaced every 3–4 d.
Transplantation of keratinocyte DEHD constructs to athymic
mice DEHD-keratinocyte constructs (IMKc.T.lacZ,/DEHD, n 5 6
IMKc/DEHD, n 5 6, and normal Kc/DEHD, n 5 6) were transplanted
to a total of 18 athymic mice (male CRL:CD-1 nude mice) using our
previously described protocol (Medalie et al, 1996). Prior to removing the
DEHD-keratinocyte construct from the culture dish, any keratinocytes
directly adjacent to the DEHD were physically removed with a needle.
These keratinocytes adhere to the keratinocytes on the DEHD and can
act as a tether to pull the epithelium off of the DEHD when it is lifted
from the dish. The DEHD-keratinocyte constructs were placed on a full-
thickness wound that was sized to fit the construct. The graft construct
was anchored at each corner with a 6–0 suture through the graft, mouse
skin, and underlying musculature. Antibiotic ointment was applied to a
square piece of nonstick gauze, applied to the graft and secured to the
surrounding mouse skin with several 6–0 sutures. The rest of the wound
care and complex dressing followed our published protocol (Medalie et al,
1996). Bandages were left in place for the duration of the experiment.
The bandages were checked daily and the Coban dressing was changed
when it became torn or loose.
Three mice were sacrificed in each group at 4 and 6 wk, the bandages
were carefully removed, and the grafts were excised and placed in PBS.
One-half of each of the normal Kc-DEHD constructs and the IMKc-
DEHD constructs were fixed in formalin and embedded in paraffin. The
other half was embedded in OCT, frozen, and stored at –70°C. For the
IMKc.T.lacZ.c-DEHD constructs, one-third were stained with X-gal
(Dannengerg and Suga, 1981) and embedded in paraffin, one-third was
not stained, fixed in formalin, and embedded in paraffin, and the final
one-third was embedded in OCT frozen and stored at –70°C.
Immunohistochemistry To ascertain the expression of differentiation
and proliferation markers in the three DEHD-keratinocyte constructs
paraffin sections of each specimen were incubated with the following
primary antibodies: loricrin (Berkeley, Richmond, CA), involucrin (Sigma,
St. Louis, MO), cytokeratin 10, cytokeratin 14, collagen type IV, laminin,
CD-29 (human β1-integrin), and PCNA (all from Biogenex, San Ramon,
CA). Detection of binding utilized an appropriate secondary antibody and
an alkaline phosphatase detection kit with fast red as the substrate (Biogenex).
Slides were counter-stained with hematoxylin. Frozen sections of DEHD-
keratinocyte constructs were assessed for bullous pemphigoid antigen 2
expression using an antibody purified from a patient suffering from bullous
pemphigoid (generously supplied by the laboratory of Dr. John J. Zone,
Department of Dermatology, University of Utah, Utah).
Cell cycle analysis, metaphase spread analysis, localization of trans-
genes with primed in situ labeling (PRINS) Normal Kc (passage 5),
IMKc, and IMKc.T.lacZ.c (at passages later than those used to seed the
DEHD µ passage 20) were submitted, on ice, as a single cell suspension
(1 3 106 cells per ml) in PBS, after fixation in cold methanol, for cell
cycle analysis in the flow cytometry facility of the Huntsman Cancer
Center at the University of Utah. Cycle analysis was generated with a
Becton Dickinson Flow Cytometer (Becton Dickinson, San Jose, CA)
with Becton Dickinson Cell Quest Software.
These same cells were also analyzed for karyotypic changes via metaphase
analysis at the Cytogenetics/FISH Core Facility of the Huntsman Cancer
Center at the University of Utah. Chromosomal localization of transgenes
HPV16-E6/E7 and lacZ were localized using PRINS. Primers for HPV16-
E6/E7 (UPLXSNH and RPLXSNH) were supplied by N. Matsunami.
The upper and lower sequences for the lacZ primer, -ccaacagttgcgcagcctga-
and -aattcgcgtctggccttcct-, respectively, were generated by the DNA/
peptide synthesis center at the University of Utah Health Sciences Center.
In situ hybridization with human specific DNA probe Histologic
sections of grafts that contained the graft constructs and the surrounding
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mouse skin were subjected to the preparative protocol recommended by
the company supplying the total human DNA biotin labeled probe (P5080-
DG.5, supplied by Oncor, Gaithersburg, MD). Protocol was followed for
hybridizing the probe and appropriate controls to the tissue sections. To
detect hybridization, HRP labeled antibiotin diluted 1:1000 was added for
1 h. Signal was amplified using the protocol provided in the Tyramide
Signal Amplification Kit (TSA-Indirect, New England Nuclear Life Sciences
Products, Boston, MA). After washing excess TSA reagent from the slides,
one drop of fast red chromogen (Biogenex, San Ramon, CA) was added
and development monitored on a slide by slide basis.
RESULTS
Kc transduced with E6/E7 demonstrated prolonged survival
in vitro Following G418 selection, the IMKc displayed normal
doubling times with no evidence of diminished growth in vitro
after more than 50 passages, and could be recovered and expanded
after cryopreservation in liquid nitrogen. Furthermore, they dis-
played the capacity to differentiate in vitro, i.e., form islands of
keratinocytes composed of germinal cells covered by differentiated
keratinocytes.
The IMKc were transduced with a retrovirus encoding lacZ and
cloned by limiting dilution (IMKc.T.lacZ.c). Several clones were
selected: the clone expressing the lacZ transgene and utilized for
the subsequent experiments has also been passaged .50 times
(µ150 cell doublings), cryopreserved, recovered, and expanded
further in vitro. These doubly transduced cells also demonstrated
the capacity to differentiate in vitro.
Immortalized keratinocytes have an abnormal karyotype
and the transgenes localize to chromosomes 9 and
10 Fluorescence-activated cell sorter analysis of the normal ker-
atinocytes, the IMKc, and the IMKc.T.lacZ.c demonstrated no
significant hypo- or hyperdiploidy. In addition, there were no
differences in the cell cycle profile (G1, G2, S, and M) of the three
cell sources.
Chromosome analysis of IMKc.T.lacZ.c showed a complex
karyotype with abnormalities involving chromosomes X, 3, 10,
13, and 14. A translocation of the long arms of chromosomes 13
and 14 was observed and the X chromosome had extra material
on the long arm that appeared to be part of the short arm of
chromosome 3. In addition, a derivative chromosome 10 involving
chromosomes 3 and 10 was present. These abnormalities were
noted on all of the IMKc.T.lacZ.c examined in metaphase. All of
the immortalized Kc that had not been transduced with the lacZ
vector, i.e., the parent line for IMKc.T.lacZ.c, were noted to have
the translocation of the long arms of chromosome 13 and 14, and
some showed the derivative chromosome X or the derivative
chromosome 10. These findings support the clonality of the
IMKc.T.lacZ.c. Chromosomal analysis of the fibroblasts from this
same source showed a normal male chromosome complement with
none of the structural abnormalities involving chromosomes X, 3,
10, 13, and 14 seen in the IMKc.
PRINS was employed as an additional method to show clonality
and to localize the site of incorporation of the two transgenes.
With PRINS, the E6/E7 insert was localized to the heterochromic
region of 9q12. A single fluorescent signal localized lacZ to
chromosome 10 (Fig 1a, b).
Expression of lacZ by E6/E7 keratinocytes is prolonged
in vivo Non-immortalized fibroblasts stably transduced with retro-
viral vectors lose transgene expression in vivo, whereas immortalized
murine fibroblasts do not (Krueger et al, 1994, 1997; Petersen
et al, 1995). All reports of expression of transgenes by normal
keratinocytes in vivo note significant loss of expression within 6 wk
(Gerrard et al, 1993; Fenjves et al, 1994, 1996, 1997; Jensen et al,
1994; Stockschlader et al, 1994; Choate and Khavari, 1997a, b).
To ascertain the effect of immortalization on transgene expression
by keratinocytes in vivo, an IMKc.T.lacZ clone was seeded onto
the acellular dermis and transplanted to athymic mice. At 4 and 6
wk these grafts were removed and analyzed for transgene expression.
Uniform expression of the transgene throughout the epidermis was
seen at both time points (Fig 2). The number of keratinocytes
expressing the transgene was the same at 4 and 6 wk. Finger-like
extensions of cells not expressing the transgene were noted at the
edges of the grafts. To determine the origin of these transgene
negative cells (human versus mouse), histologic sections were probed
with a human specific DNA probe (Fig 3). All cells expressing the
transgene were human, whereas those not expressing the transgene
were not. This suggests that host (mouse) keratinocytes had grown
onto the acellular dermis at some graft edge sites. The presence of
murine keratinocytes growing on the acellular dermis was confirmed
by immunohistochemical staining for involucrin, a human specific
antibody (see below).
Immortalized keratinocytes form a normal epidermis
in vivo The histology of the epidermis formed in vivo by cloned,
immortalized keratinocytes grown on an acellular dermis (DEHD)
was strikingly similar to that produced by normal (nonimmortalized)
keratinocytes. Histologic analysis was carried out on the composite
grafts of normal keratinocytes, and the IMKc.T.laZ.c composites
harvested at 6 wk (Fig 4). There were no substantive morphologic
differences between the epidermis generated from the
IMKc.T.lacZ.c and that generated from normal keratinocytes. Both
displayed a normally differentiated epidermis and stratum corneum.
No dyskeratotic keratinocytes were noted in the epidermis formed
by the immortalized cells, nor was there evidence of invasion into
the dermis.
This pattern of normal differentiation prompted a survey of
expression of differentiation markers (keratins 10 and 14, involucrin,
loricrin) and proliferation (PCNA) in the composite grafts. Expres-
sion of K10 (Fig 5) and involucrin (Fig 6) was not altered in
the grafts containing immortalized keratinocytes: distribution and
expression of both were identical to that generated by composite
grafts comprised of normal keratinocytes. Involucrin expression in
all composite grafts was less than that seen in normal skin in vivo.
Also, involucrin was not expressed in areas where mouse ker-
atinocytes occupied the DEHD, as the antibody to involucrin is
human specific.
PCNA expression in grafts containing IMKc.T.lacZ.c and normal
keratinocytes were identical, but higher than that seen in control
split-thickness human skin grafts (data not shown).
The expression of several selected components of the cutaneous
basement membrane (type IV collagen, β1-integrin, bullous pem-
phigoid antigen 2, and laminin) was also assessed in normal
skin and the composite grafts. Grafts comprised of normal and
immortalized keratinocytes demonstrated no differences in expres-
sion of these components. Expression of bullous pemphigoid
antigen 2, laminin, and β1-integrin was less in reconstituted skin
constructs than in normal skin, suggesting that these structural
components had not completely formed in the composite grafts by
6 wk. Type IV collagen in normal skin was confined to the
basement membrane and the blood vessels; however, in the
composite grafts collagen was distributed in a broader band at the
basement membrane (Fig 7).
DISCUSSION
These studies suggest a number of reasons for using immortalized
keratinocytes to further understand the use of keratinocytes in gene
therapy. First, immortalized keratinocytes can be transduced with
a second transgene and these cells can be cloned to generate
progeny of an identical phenotype and genotype. These cells
withstand cloning by limiting dilution which have been taken
through at least 150 cell doublings. Normal keratinocytes will not
withstand the pressure of this type of cloning and cannot, with the
medium we used, be expanded after µ20 cell doublings. Second,
fluorescence-activated cell sorter analysis reveals that the IMKc
have no evidence of hyper- or hypo-diploidy and display a normal
G1, S, G2, and M profile. As noted, the IMKc do have an abnormal
karyotype linked to the transduction with HPV E6/E7 and sub-
sequent selection in G418; the subsequent transduction with lacZ
did not add any abnormalities to the karyotype. Because an
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Figure 1. Clonality and location of the transgenes of immortalized
keratinocytes encoded with lacZ. FISH, with primers to E6/E7 genes
of HPV to a metaphase spread [bottom of (a)], localizes E6/E7 to
chromosome 9q12 [top of (a)]. PRINS, with primers to lacZ to a metaphase
spread [bottom of (b)], localizes lacZ to chromosome 10 [top of (b)].
Figure 2. Transgene expression and epidermal differentiation of
genetically modified IMKc in vivo. IMKc were cloned for expression
of lacZ transgene, seeded on an acellular dermis, transplanted to nude
mice, harvested 6 wk later (n 5 3), stained with X-gal, and sectioned for
histologic exam. Scale bars: (a) 160 µM, (b) 40 µM.
epidermis with a normal phenotype was generated in vivo we do
not know the significance of the abnormalities in the karyotype.
Third, transgene expression in the IMKc is prolonged in vivo; no
loss of expression was noted at the end of this 6 wk experiment.
In contrast, it is our experience as well as that of all other
investigators in this field that, with nonimmortalized cells, retroviral
mediated transgene expression begins to diminish shortly after
transfer to an in vivo setting and is usually absent by 6 wk (Gerrard
et al, 1993; Fenjves et al, 1994, 1996, 1997; Jensen et al, 1994;
Stockschlader et al, 1994; Choate and Khavari, 1997a, b). This is
true even when .99% of the keratinocytes express the transgene
at the time of transfer in vivo (Choate and Khavari, 1997b). Thus,
the fact that no loss of transgene expression was seen within the 6
wk time frame is significant, and strongly supports the hypothesis
that transgene expression will be sustained for longer periods of
time in vivo when long-lived cells are used. Fourth, the epidermis
Figure 3. Transgene expression is confined to cloned human
keratinocytes. Photomicrographs of histologic sections from representative
composite skin grafts (n 5 3) stained for lacZ expression of Fig 2 probed
with biotin labeled human-specific DNA. The probe was developed with
alkaline phosphatase–fast red. (a) lacZ positive area probed with human-
specific DNA; (b) demonstration of area of graft with lacZ positive and
lacZ negative areas; (c) histology of lacZ positive and negative areas
counterstained with hematoxylin. Scale bars: 40 µM.
produced by these cells appears normal and is comparable with
that produced by normal keratinocytes. Markers of differentiation
and basement membrane components are similar in both. Also, the
epidermis formed by the immortalized cells does not demonstrate
abnormal growth or invasive characteristics. The rate of growth,
as measured by time to reach confluence in the growth conditions
used in these experiments, of the IMKc in vitro does not differ
substantively from that of normal Kc (data not presented). This is
reflected in vivo; the PCNA expression in the IMKc and normal
Kc composite grafts are not different.
These features generate enthusiasm for utilizing HPV16-E6/E7
immortalized human keratinocytes to correct diseases that are
approachable via genetically modified keratinocytes; however,
because abrogation of growth arrest signals by HPV16-E6/E7 has
been associated with morphologic evidence of transformation of
human keratinocytes grown on collagen rafts in vitro, a note of
caution is appropriate (Demers et al, 1996). Increasingly, it is
appreciated that the interaction of epithelium with its stroma directs
the development of normal as well as abnormal cellular proliferation
and differentiation (Boudreau et al, 1995, 1996; Wilding et al, 1996;
Turner et al, 1997). Thus, it is possible that the HPV16-E6/E7
transformed human keratinocytes may have encountered messages
that inhibit progression to a transformed or malignant phenotype,
when seeded on a physiologic substrate (the DEHD) and trans-
planted into an in vivo setting with mammalian nutrients and
mediators.
This report is generated from ‘‘proof of principle’’ experiments.
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Figure 4. Histology of INKc forms a functional epidermis. Photo-
micrographic demonstration of representative histology of composite grafts
(n 5 3) of early passage normal keratinocytes and cloned immortalized
lacZ expressing keratinocytes on the acellular dermis after 6 wk of
engraftment on nude mice: (a) normal Kc on an acellular dermis at 2503;
(b) immortalized lacZ expressing keratinocytes on an acellular dermis at
2503; (c) lacZ expressing keratinocytes on an acellular dermis at 4003.
Scale bars: (a, b) 64 µM, (c) 40 µM.
Prior to any use of HPV16-E6/E7 immortalized keratinocytes in
a clinical setting, studies on composite grafts in vivo that extend
well beyond 6 wk are needed. Longer observation times will
address many issues: whether tumors might ultimately develop, the
latency of such tumors, the role of carcinogens, wound healing,
and possible tumor development (the ‘‘second hit’’ hypothesis), as
well as a further determination of the durability of transgene
expression. It is appreciated that in some particularly disabling skin
diseases, the risk of spontaneously developing tumors might be
acceptable, e.g., in the dystrophic forms of epidermolysis bullosa.
Survival of transgene expression in 100% of the human cells for
6 wk is a surprising and significant finding. It suggests that processes
that lead to immortalization inhibit mechanisms that switch off
transgenes inserted in the host genome by retroviral vectors in vivo,
and/or inhibit in vivo apoptosis of cells that have been stably
transduced ex vivo. Additional strategies for prolonging the life span
of cells, such as overexpression of telomerase (Bodnar et al, 1998),
may significantly promote the clinical application of gene therapy
using keratinocytes.
A criticism of these ‘‘proof of principle’’ experiments relates to
Figure 5. IMKc differentiate in a normal fashion. Immunohisto-
chemical demonstration of the expression of keratin 10 (K10) of transplanted
normal human skin (a), early passage normal keratinocytes on the acellular
dermis (b), and cloned immortalized lacZ expressing keratinocytes
(n 5 3) on the acellular dermis (c) after 6 wk of engraftment on nude
mice. Binding of antibody specific to K10 was developed with alkaline
phosphatase–fast red, and sections were counterstained with hematoxylin.
Scale bars: 40 µM.
not doing a meaningful control, a composite graft of normal Kc
transduced with lacZ. As noted, transduced Kc will not survive
the rigors of cloning by limiting dilution. We have conducted
identical experiments with normal Kc transduced with lacZ where
30% of the Kc expressed the transgene after transduction. Composite
grafts generated from these Kc were transplanted to nude mice.
Loss of expression was dramatic: µ50% at 4 wk and .90% at
8 wk. At 8 wk isolated lacZ-expressing Kc were noted at the
basement membrane with occasional columns of lacZ-expressing
Kc. We interpret this to be compatible with the notion that
transduction of both stem cells and transient amplifying cells were
transduced in vitro and that with time in vivo the transgene expression
was lost in the transient amplifying population.1 It is also emphasized
that in these experiments, which parallel the experiments reported
here, there is significant and dramatic loss of transgene expression
when normal human keratinocytes are used.
1J Invest Dermatol 104:573, 1995 (abstr.)
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Figure 6. IMKc expresses involucrin in a normal fashion.
Immunohistochemical demonstration of the expression of involucrin of
transplanted normal human skin (a), early passage normal keratinocytes
on the acellular dermis (b), and cloned immortalized lacZ expressing
keratinocytes on the acellular dermis (c) after 6 wk of engraftment on nude
mice (n 5 3). Binding of antibody specific to involucrin was developed
with alkaline phosphatase–fast red. Scale bars: 40 µM.
The observation that cells with stem cell properties exist in
cultures of keratinocytes from foreskin has recently been further
delineated (Mathor et al, 1996; Kolodka et al, 1998). Mathor et al
noted that foreskin keratinocytes expressing retrovirally encoded
transgenes can be cloned from individual cells using irradiated 3T3
feeder layer technology. Some clones had pronounced growth
potential in vitro (.150 cell doublings); causing the authors to
conclude these represented stem cells. When epidermal sheets
derived from these clones were transplanted to athymic mice,
however, graft failure ensued within 7 d (Mathor et al, 1996). More
recently Kolodka et al reported that µ25% of foreskin keratinocytes
expressing retrovirally encoded transgenes had enhanced prolifer-
ative capacity (.30 cell doublings) in vitro. Epidermal sheets
generated from keratinocytes containing this population were
transplanted to athymic mice, recovered after varying time intervals,
seeded at clonal density, and assessed for transgene expression. The
frequency of expression after recovery was similar to that before
transplant, µ25%. In agreement with our 1995 report, see above,
was their observation of isolated transgene expressing cells in the
germinative compartment and the observation that transduced cells
gave rise to columns of transgene-expressing daughter cells. They
Figure 7. IMKc form normal basement membrane components.
Immunohistochemical demonstration of type IV collagen expression in
transplanted normal human skin (a), early passage normal keratinocytes
on the acellular dermis (b), and cloned immortalized lacZ expressing
keratinocytes on the acellular dermis (c) after 6 wk of engraftment on nude
mice (n 5 3). Binding of antibody specific to type IV collagen was developed
with alkaline phosphatase–fast red and sections were counterstained with
hematoxylin. Scale bars: 40 µM.
conclude that cultures of keratinocytes contained cells with long-
term growth potential in vivo (Kolodka et al, 1998).
Keratinocytes have a limited capacity to proliferate in vitro,
especially in defined media with no feeder cell layer. Selected
keratinocytes from foreskin or hair bulbs can undergo µ150 cell
doublings when grown with feeder layers (Mathor et al, 1996;
Kolodka et al, 1998); however, under culture conditions used in
these experiments, greater than 20 cell doublings are rarely seen
and they cannot be cloned. Thus, having generated a keratinocyte
line, using standard immortalization protocols, that withstands the
pressure of cloning and has gone through more than 150 cell
doublings in our culture conditions, supports the probability that
we have generated an immortalized cell line. If not immortal they
are very long lived and can be used to generate large numbers of
genetically modified daughter cells.
Other approaches to generating sustained transgene expression
by human keratinocytes in vivo are being pursued. Investigators
working with Dr. Khavari have generated a retroviral vector where
the promoter and enhancer sequences of the LTR were deleted
and inactivated. Transgene expression was noted in the epidermis
of skin generated from Kc carrying this vector after 10 wk of
transplantation to immunodeficient mice (Deng et al, 1997). This
suggests that cells expressing retroviral components may be more
susceptible to apoptosis or that transgenes carrying LTR as a
promoter are more readily inactivated.
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The continued expression of stably integrated transgenes by
immortalized keratinocytes in vivo makes it possible to further
examine the use of keratinocytes in gene therapy. It will be possible
to model systemic delivery of transgene products from a genetically
modified epidermis. The rapid loss of transgene expression by
genetically modified normal keratinocytes in vivo (Gerrard et al,
1993; Fenjves et al, 1994, 1996, 1997; Jensen et al, 1994;
Stockschlader et al, 1994; Choate and Khavari, 1997a, b) makes it
difficult to assess the pharmacokinetics of transgene expression in
systems where the delivery system is deteriorating at an unknown
rate.
It has recently been demonstrated that overproduction of ‘‘natural
immunosuppressants’’, e.g., FasL, will prolong engraftment of
foreign tissue (Lau et al, 1996; Zhang et al, 1997). Development of
an immortalized keratinocyte producing a ‘‘natural immuno-
suppressant’’ would allow exploration of the concept of a universal
donor keratinocyte, a cell producing a local immunosuppressant
and thereby escaping rejection by the immune system of the host.
Funding provided by a grant from the National Institutes of Health PO1
HD28528.
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